| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Classified under Pharmaceuticals (Health Care sector), BCRX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 1.34M | $13.00M | - | |
| CFO | 268.7K | - | - | |
| Other | 205.2K | - | - | |
| Dir | 109.6K | $1.06M | - | |
| Dir | 80.6K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 19, 2018 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 3,150 | $7.45 | $23,467.50 | -2.2% | |
| Oct 3, 2018 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 9,850 | $7.24 | $71,357.78 | -6.7% | |
| Aug 9, 2018 | Sheridan William P67 | Senior VP - CMO | Sale+OE | 62,500 | $7.03 | $439,375.00 | -72.9% | |
| Jun 1, 2018 | Sheridan William P67 | Senior VP - CMO | Sale+OE | 42,112 | $6.30 | $265,305.60 | -66.7% | |
| Nov 13, 2017 | Sheridan William P67 | Senior VP - CMO | Sell | 64,310 | $4.72 | $303,543.20 | -72.9% | |
| Sep 18, 2017 | Cohen Fred E | Director | Sale+OE | 54,250 | $5.42 | $294,035.00 | -31.2% | |
| Mar 20, 2017 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 3,250 | $9.20 | $29,900.00 | -2.2% | |
| Mar 10, 2017 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 3,250 | $9.06 | $29,445.00 | -2.7% | |
| Mar 8, 2017 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 6,500 | $8.43 | $54,762.50 | -5.2% | |
| Mar 6, 2017 | Staab Thomas R II | Senior Vice President And CFO | Sale+OE | 3,250 | $7.90 | $25,675.00 | -2.7% |